AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Partnering to unlock the true potential of cannabis in medical care
Archives: News
AI able to ‘predict impact of minor changes’ to manufacturing
Industry 4.0 has been pitched as able to transform the way pharma manufacturing operates, Lawrence Ganti…..
Blockchain in Healthcare: 6 Possible Use Cases
According to one study, the United States healthcare system ranked last among 11 industrialized nations in terms of access, equity, quality, efficiency, and healthy lives. And it’s not as if there was foreign bias skewing the results — the Commonwealth Fund, which published the study, is a U.S.-based foundation aiming to improve the overall state …
5 predictions for AI in 2019
While several companies touted the potential of AI to disrupt the drug development industry in 2018, what practical applications can the industry expect next year? Artificial intelligence (AI) made waves in the pharmaceutical industry last year, with several large-scale deals, partnerships, and announcements, as researchers predict a revolution in drug discovery and preclinical development. In …
Five AI Healthcare Startups Bringing Us Closer to Cures
Clinical Informatics tells us that: “Every year in the U.S., approximately 2 million patients participate in roughly 3000 clinical trials; six million patients are needed to meet U.S. recruitment goals. Consequently, up to 90% of trials are delayed or over budget”. Experts blame the lack of data available – to both patients and researchers – …
Five AI Healthcare Startups Bringing Us Closer to Cures Read More »
Innoplexus Brings Blockchain to Pharma
Global AI firm Innoplexus launched an innovative blockchain platform to dramatically raise the amount of data available for drug research and discovery. This new platform, an update to Innoplexus’ flagship product iPlexus is the first of its kind and will enable researchers to upload and license unpublished data on the blockchain to facilitate collaboration, reduce …
Founder fights cancer with artificial intelligence
Gunjan Bhardwaj helps pharmaceutical companies to find out more about diseases. By harnessing artificial intelligence, pharmaceutical companies are able to develop drugs more quickly. Frankfurt. It was a life-changing experience for Gunjan Bhardwaj to have a dear friend diagnosed with cancer years ago. In a desperate attempt to help, Bhardwaj, an Indian-born businessman, scavenged the …
Founder fights cancer with artificial intelligence Read More »
AI-based drug development to broaden gap between pharmaceuticals
Local pharmaceutical firms should brace for a new era where drugmakers take advantage of artificial intelligence (AI) to develop a new medicine, experts said. The AI-using new drug development has already become the latest trend and doing so will save cost and time, they said at a news conference at the AI Pharma Korea Conference …
AI-based drug development to broaden gap between pharmaceuticals Read More »
Google for Pharma
Indian and Swabian Together with friends from India, Gunjan Bhardwaj has successfully launched Innoplexus, a sophisticated ecosystem of continuous analytics, powered by artificial intelligence and machine learning.The goal: Innoplexus wants to become the European champion for AI. The chances: excellent. At 35, Gunjan Bhardwaj was an aspiring management consultant at Ernst & Young. The atmosphere …
We want to democratize data
Dr. Gunjan Bhardwaj is the founder and CEO of Innoplexus AG. With the help of artificial intelligence, blockchain and big data analysis applications, its iPlexus software has crawled over 300 terabytes of relevant clinical and medical data and put them in a logical context, being constantly updated and delivered to the workstations of customers in …
